UK investors are buying Fulgent and Carnival shares, says Fineco

UK investors are looking at the US market for top growth opportunities, according to the latest data from trading platform Fineco.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Buying US shares is easier than ever for UK investors. Share trading platform Fineco says that top US healthcare and pharma stocks were among the most popular with UK investors last week.

Topping the list was biotech company Fulgent Genetics. NASDAQ-listed Fulgent is heavily involved in Covid-19 testing and recently reported a 3,400% increase in quarterly revenue.

Another big trend highlighted by Fineco’s data was the trade in reopening stocks. This included big names in the US and UK travel sectors, such as Carnival and Rolls-Royce.

Here’s my take on the biggest movers reported by Fineco this week.

US shares lead the way

UK traders on Fineco’s platform seem to be spending a lot of their time focusing on fast-moving US stocks. The top five movers last week were all US-listed firms in the pharma and tech sectors.

In first place was Fulgent Genetics. This company specialises in genetic testing that provides clinically actionable information. But it’s Fulgent’s success in Covid-19 testing that has boosted its share price by 760% over the last year.

Fulgent says that revenue rose by 1,200% to $422m in 2020. The firm expects this figure to rise by 90% to $800m in 2021, including $70m from its next generation sequencing genetic testing service.

Fulgent shares are priced on a modest multiple of 8.5 times 2021 forecast earnings, but brokers expect earnings to fall by 70% in 2022 as the Covid-19 pandemic recedes.

Other top US stocks that were heavily traded by Fineco’s UK investor clients last week included vaccine firm Moderna, Regeneron Pharmaceuticals, and China-based tech stocks SOS Ltd and Lizhi Inc.

Two notable names that were out of favour were Airbnb and Germany car stock Volkswagen. Both were sold heavily on the Fineco platform last week.

UK investors buy reopening stocks

What about UK shares? Fineco’s traders showed plenty of interest in their home market too. Reopening stocks led the way. These are companies that are expected to benefit from a return to normal as the UK exits lockdown.

The world’s largest cruise ship operator, Carnival, was one of Fineco’s top UK movers. Other stocks that caught buyers’ interest included The Gym Group and budget airline Wizz Air.

Travel and leisure weren’t the only themes. Gold miners Centamin and Polymetal International both saw strong buying on Fineco. Both of these big producers have reported solid financial results recently.

Centamin’s net profit rose by 78% to $156m last year, while Polymetal’s earnings rose by 125% to $1,086m. The outlook is positive for both businesses, according to their respective CEOs.

Elsewhere, the prospects for housebuilders seemed to divide opinion among Fineco’s UK investors. Investors bought and sold equal volumes of shares in housebuilder Crest Nicholson last week.

Outsourcer Serco Group received a similar split decision, but investors turned cautious on grocer Wm Morrisons Supermarkets. Investors trading the Bradford-based supermarket’s shares sold two shares for every one they bought. I think this weakness could reflect concerns that shoppers will start spending more widely as the economy reopens.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Roland Head owns shares of Polymetal International. The Motley Fool UK owns shares of and has recommended Fulgent Genetics, Inc. The Motley Fool UK has recommended Airbnb, Inc., Moderna Inc., Morrisons, The Gym Group, and Wizz Air Holdings. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »